Employers, lawmakers and more said regulators should hustle to get disclosure mandates for the controversial drug middlemen across the finish line, while PBMs slammed the rule as illegal, unnecessary and anticompetitive.
https://www.hrdive.com/news/dol-pbm-transparency-rule-comments/817946/